Pages that link to "Q42495577"
Jump to navigation
Jump to search
The following pages link to Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Q42495577):
Displaying 50 items.
- A Brief History of Pallidotomy (Q22242789) (← links)
- Functional anatomy of movement disorders (Q24544908) (← links)
- The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat (Q24675262) (← links)
- The pedunculopontine tegmental nucleus-A functional hypothesis from the comparative literature. (Q28066837) (← links)
- Localization of calcium-binding proteins and GABA transporter (GAT-1) messenger RNA in the human subthalamic nucleus (Q28141140) (← links)
- Pathology of idiopathic dystonia: findings from genetic animal models (Q28268838) (← links)
- Anatomy, physiology, and pathophysiology of the pedunculopontine nucleus (Q28304606) (← links)
- The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats (Q28482094) (← links)
- The indirect basal ganglia pathway in dopamine D(2) receptor-deficient mice (Q28591849) (← links)
- An update on the connections of the ventral mesencephalic dopaminergic complex. (Q30401219) (← links)
- The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma. (Q30622098) (← links)
- Kainate acid lesions of the pedunculopontine region in the normal behaving primate (Q32052267) (← links)
- Frontal syndrome as a consequence of lesions in the pedunculopontine tegmental nucleus: a short theoretical review (Q33541465) (← links)
- The pallidofugal projection system in primates: evidence for neurons branching ipsilaterally and contralaterally to the thalamus and brainstem (Q33697330) (← links)
- Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial (Q33870490) (← links)
- Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients (Q33893379) (← links)
- Functional changes of the basal ganglia circuitry in Parkinson's disease. (Q33924857) (← links)
- The selective vulnerability of striatopallidal neurons (Q33939097) (← links)
- REM sleep atonia: responsible brain regions, quantification, and clinical implication (Q34031065) (← links)
- Pathophysiology of the basal ganglia in Parkinson's disease. (Q34070859) (← links)
- Dopamine-mediated regulation of striatal neuronal and network interactions (Q34070883) (← links)
- Metabolic effects of nigrostriatal denervation in basal ganglia. (Q34070899) (← links)
- Remacemide: current status and clinical applications (Q34074824) (← links)
- Occupational complexity and risk of Parkinson's disease (Q34149818) (← links)
- Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia. (Q34165820) (← links)
- Pathophysiology of levodopa-induced dyskinesia: potential for new therapies (Q34325365) (← links)
- Functional and pathophysiological models of the basal ganglia (Q34413699) (← links)
- Disorders of the reticular activating system (Q34451487) (← links)
- The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys (Q34566620) (← links)
- Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back (Q34596340) (← links)
- Pathophysiology of parkinsonism (Q34777496) (← links)
- Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release (Q34792220) (← links)
- Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state (Q35053448) (← links)
- Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease (Q35053904) (← links)
- Presymptomatic compensation in Parkinson's disease is not dopamine-mediated (Q35104797) (← links)
- Pathological basal ganglia activity in movement disorders (Q35532146) (← links)
- Correlates of movement initiation and velocity in Parkinson's disease: A longitudinal PET study (Q35679768) (← links)
- Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism (Q35866836) (← links)
- Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET. (Q36071428) (← links)
- The use of thalamotomy in the treatment of levodopa-induced dyskinesia (Q36085030) (← links)
- Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa (Q36085612) (← links)
- Role of nitric oxide on motor behavior (Q36209135) (← links)
- Sleep in aging and neurodegenerative diseases. (Q36233214) (← links)
- The pedunculopontine tegmental nucleus and experimental parkinsonism. A review (Q36285103) (← links)
- Non-Human Primate: An Essential Building Brick in the Discovery of the Subthalamic Deep Brain Stimulation Therapy (Q36452960) (← links)
- Control of gene expression by transmitters and peptide hormones (Q36552712) (← links)
- Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease (Q36674371) (← links)
- Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data (Q36687216) (← links)
- Thalamotomy for the alleviation of levodopa-induced dyskinesia: Experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey (Q36696577) (← links)
- GABAergic circuits in the basal ganglia and movement disorders (Q36820627) (← links)